|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/10 | (2006.01) |
| A61K 38/26 | (2006.01) | ||
| A61M 5/142 | (2006.01) |
| (11) | Number of the document | 2462246 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10819152.9 |
| Date of filing the European patent application | 2010-09-21 | |
| (97) | Date of publication of the European application | 2012-06-13 |
| (45) | Date of publication and mention of the grant of the patent | 2017-09-06 |
| (46) | Date of publication of the claims translation | 2017-11-27 |
| (86) | Number | PCT/US2010/002591 |
| Date | 2010-09-21 |
| (87) | Number | WO 2011/037623 |
| Date | 2011-03-31 |
| (30) | Number | Date | Country code |
| 358112 P | 2010-06-24 | US | |
| 277724 P | 2009-09-28 | US |
| (72) |
ALESSI, Thomas, R., US
LUSKEY, Kenneth, L., US
|
| (73) |
Intarcia Therapeutics, Inc,
One Marina Park Drive, Suite 1300, Boston, MA 02210,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas |
| RAPID ESTABLISHMENT AND/OR TERMINATION OF SUBSTANTIAL STEADY-STATE DRUG DELIVERY |
| Payment date | Validity (years) | Amount | |
| 2023-08-31 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-09-21 |